Switch to:
Also traded in: Germany, Israel

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash-to-Debt 26.41
PHMD's Cash-to-Debt is ranked higher than
69% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.87 vs. PHMD: 26.41 )
Ranked among companies with meaningful Cash-to-Debt only.
PHMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: 1.83 Max: No Debt
Current: 26.41
Equity-to-Asset 0.05
PHMD's Equity-to-Asset is ranked lower than
94% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. PHMD: 0.05 )
Ranked among companies with meaningful Equity-to-Asset only.
PHMD' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.08  Med: 0.7 Max: 0.91
Current: 0.05
-0.08
0.91
Debt-to-Equity 0.04
PHMD's Debt-to-Equity is ranked higher than
88% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 0.27 vs. PHMD: 0.04 )
Ranked among companies with meaningful Debt-to-Equity only.
PHMD' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.42  Med: 0.13 Max: 2.26
Current: 0.04
-1.42
2.26
Debt-to-EBITDA -0.03
PHMD's Debt-to-EBITDA is ranked lower than
99.99% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. PHMD: -0.03 )
Ranked among companies with meaningful Debt-to-EBITDA only.
PHMD' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -5.96  Med: -1.09 Max: 1.25
Current: -0.03
-5.96
1.25
Piotroski F-Score: 5
Altman Z-Score: -8.73
Beneish M-Score: -5.62
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % -28.82
PHMD's Operating Margin % is ranked lower than
70% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. PHMD: -28.82 )
Ranked among companies with meaningful Operating Margin % only.
PHMD' s Operating Margin % Range Over the Past 10 Years
Min: -53  Med: -17.02 Max: 25.93
Current: -28.82
-53
25.93
Net Margin % -21.95
PHMD's Net Margin % is ranked lower than
66% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. PHMD: -21.95 )
Ranked among companies with meaningful Net Margin % only.
PHMD' s Net Margin % Range Over the Past 10 Years
Min: -91.38  Med: -26.33 Max: 16.56
Current: -21.95
-91.38
16.56
ROE % -413.65
PHMD's ROE % is ranked lower than
98% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. PHMD: -413.65 )
Ranked among companies with meaningful ROE % only.
PHMD' s ROE % Range Over the Past 10 Years
Min: -413.65  Med: -23.91 Max: 55.77
Current: -413.65
-413.65
55.77
ROA % -34.66
PHMD's ROA % is ranked lower than
74% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.11 vs. PHMD: -34.66 )
Ranked among companies with meaningful ROA % only.
PHMD' s ROA % Range Over the Past 10 Years
Min: -59.58  Med: -16.1 Max: 22.6
Current: -34.66
-59.58
22.6
ROC (Joel Greenblatt) % -719.28
PHMD's ROC (Joel Greenblatt) % is ranked lower than
86% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.41 vs. PHMD: -719.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PHMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -719.28  Med: -38.36 Max: 163.98
Current: -719.28
-719.28
163.98
3-Year Revenue Growth Rate -44.70
PHMD's 3-Year Revenue Growth Rate is ranked lower than
94% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. PHMD: -44.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PHMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -8.2 Max: 139.9
Current: -44.7
0
139.9
GuruFocus has detected 3 Warning Signs with PhotoMedex Inc PHMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PHMD's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with PHMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:OTCPK:VYCO, ASX:ACG, OTCPK:PBIO, XTAE:MDGS, ASX:RHT, ASX:MOT, OTCPK:MRLB, XSAT:EMOT, LSE:MED, NAS:CHFS, OTCPK:AIRW, OTCPK:CRVW, TSXV:ASG, NGM:CMH MTF, XSAT:SDET, OTCPK:RMSL, AMEX:NSPR, OTCPK:IGNG, XCNQ:LNB, TSE:5212 » details
Traded in other countries:LA9N.Germany, PHMD.Israel,
Headquarter Location:USA
PhotoMedex Inc is a skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers, and provides proprietary products and services that address skin diseases.

PhotoMedex Inc is a skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers, and provides proprietary products and services that address skin diseases.

Ratios

vs
industry
vs
history
PB Ratio 0.84
PHMD's PB Ratio is ranked higher than
94% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. PHMD: 0.84 )
Ranked among companies with meaningful PB Ratio only.
PHMD' s PB Ratio Range Over the Past 10 Years
Min: 0.23  Med: 1.42 Max: 12.94
Current: 0.84
0.23
12.94
PS Ratio 0.27
PHMD's PS Ratio is ranked higher than
97% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. PHMD: 0.27 )
Ranked among companies with meaningful PS Ratio only.
PHMD' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.51 Max: 2.39
Current: 0.27
0.08
2.39
Price-to-Free-Cash-Flow 13.70
PHMD's Price-to-Free-Cash-Flow is ranked higher than
85% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 28.08 vs. PHMD: 13.70 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PHMD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.71  Med: 13.53 Max: 386.89
Current: 13.7
0.71
386.89
Price-to-Operating-Cash-Flow 13.13
PHMD's Price-to-Operating-Cash-Flow is ranked higher than
78% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 19.79 vs. PHMD: 13.13 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PHMD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.72  Med: 13.14 Max: 427
Current: 13.13
0.72
427
EV-to-EBIT 0.05
PHMD's EV-to-EBIT is ranked higher than
99% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 23.37 vs. PHMD: 0.05 )
Ranked among companies with meaningful EV-to-EBIT only.
PHMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.1  Med: -2.3 Max: 21.7
Current: 0.05
-80.1
21.7
EV-to-EBITDA 0.05
PHMD's EV-to-EBITDA is ranked higher than
99% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 17.75 vs. PHMD: 0.05 )
Ranked among companies with meaningful EV-to-EBITDA only.
PHMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -103.7  Med: -2.9 Max: 57571
Current: 0.05
-103.7
57571
EV-to-Revenue -0.01
PHMD's EV-to-Revenue is ranked lower than
99.99% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. PHMD: -0.01 )
Ranked among companies with meaningful EV-to-Revenue only.
PHMD' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 1.1 Max: 2.5
Current: -0.01
0.1
2.5
Current Ratio 1.20
PHMD's Current Ratio is ranked lower than
86% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. PHMD: 1.20 )
Ranked among companies with meaningful Current Ratio only.
PHMD' s Current Ratio Range Over the Past 10 Years
Min: 0.43  Med: 1.94 Max: 9.54
Current: 1.2
0.43
9.54
Quick Ratio 1.20
PHMD's Quick Ratio is ranked lower than
75% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. PHMD: 1.20 )
Ranked among companies with meaningful Quick Ratio only.
PHMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.13  Med: 1.22 Max: 8.92
Current: 1.2
0.13
8.92
Days Inventory 481.65
PHMD's Days Inventory is ranked lower than
94% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 139.39 vs. PHMD: 481.65 )
Ranked among companies with meaningful Days Inventory only.
PHMD' s Days Inventory Range Over the Past 10 Years
Min: 145.69  Med: 183.92 Max: 481.65
Current: 481.65
145.69
481.65
Days Sales Outstanding 0.94
PHMD's Days Sales Outstanding is ranked higher than
99% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 67.97 vs. PHMD: 0.94 )
Ranked among companies with meaningful Days Sales Outstanding only.
PHMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.94  Med: 42.48 Max: 68.17
Current: 0.94
0.94
68.17
Days Payable 130.76
PHMD's Days Payable is ranked higher than
79% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. PHMD: 130.76 )
Ranked among companies with meaningful Days Payable only.
PHMD' s Days Payable Range Over the Past 10 Years
Min: 62.12  Med: 112.18 Max: 300.09
Current: 130.76
62.12
300.09

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -4.90
PHMD's 3-Year Average Share Buyback Ratio is ranked higher than
50% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. PHMD: -4.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PHMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -132.3  Med: -18.6 Max: 0
Current: -4.9
-132.3
0

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 3.41
PHMD's Price-to-Net-Current-Asset-Value is ranked higher than
77% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 7.13 vs. PHMD: 3.41 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
PHMD' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.52  Med: 8.62 Max: 89.02
Current: 3.41
1.52
89.02
Price-to-Tangible-Book 0.84
PHMD's Price-to-Tangible-Book is ranked higher than
95% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. PHMD: 0.84 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PHMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.79  Med: 4.41 Max: 58.23
Current: 0.84
0.79
58.23
Price-to-Intrinsic-Value-Projected-FCF 4.50
PHMD's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
75% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. PHMD: 4.50 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PHMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.09  Med: 1.59 Max: 42.63
Current: 4.5
0.09
42.63
Price-to-Median-PS-Value 0.53
PHMD's Price-to-Median-PS-Value is ranked higher than
88% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. PHMD: 0.53 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PHMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.18  Med: 2.94 Max: 837.63
Current: 0.53
0.18
837.63
Earnings Yield (Greenblatt) % 2000.00
PHMD's Earnings Yield (Greenblatt) % is ranked higher than
99% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.94 vs. PHMD: 2000.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PHMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1225.1  Med: -12.5 Max: 2000
Current: 2000
-1225.1
2000

More Statistics

Revenue (TTM) (Mil) $30.70
EPS (TTM) $ -1.93
Beta0.92
Short Percentage of Float8.91%
52-Week Range $0.71 - 5.60
Shares Outstanding (Mil)5.24

Analyst Estimate

Dec17
Revenue (Mil $)
EPS ($) -0.55
EPS without NRI ($) -0.55
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAN
Positive CFROAN
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}